A Study to Identify Errors in Inhaler Technique in Adults
SCORES
A Study to Identify the Prevalence of Device Specific Errors in Inhaler Technique in Adults With Airways Disease
1 other identifier
observational
734
1 country
1
Brief Summary
This study will observe the inhaler technique of people using 13 different inhaler types; record any technique errors being made against checklists developed for each inhaler device based on their manufacturer's guidelines, and reeducate any observed inhaler technique errors as required.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 7, 2019
CompletedFirst Submitted
Initial submission to the registry
February 7, 2020
CompletedFirst Posted
Study publicly available on registry
February 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedApril 10, 2023
April 1, 2023
2.9 years
February 7, 2020
April 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
To assess the prevalence of device-specific inhaler technique errors (ITE), in 13 different devices using manufacturers' guidelines.
Device Specific inhaler technique errors
one study visit- day 1
Eligibility Criteria
Any person over the age of 16 who uses and inhaler device for an airways condition.
You may qualify if:
- Aged ≥16 years
- Have been prescribed (by a doctor or healthcare professional) 1 of 13\* inhaler device types for an airways condition.
- \*Accuhaler, Autohaler, Breezhaler, Easi-breathe, Easyhaler, Ellipta, Genuair, Handihaler, Nexthaler, pMDI, pMDI plus spacer (e.g. Aerochamber or Volumatic), Respimat and Turbohaler
- Able to provide written informed consent
You may not qualify if:
- Currently on treatment with systemic steroids and/or antibiotics for an exacerbation of the participants' airways condition.
- In the opinion of the investigator that the participant will be unable to perform the study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Portsmouth Hospitals NHS Trust
Portsmouth, PO6 3LY, United Kingdom
Related Publications (1)
De Vos R, Brown T, Longstaff J, Lomax M, Mackenzie H, Hicks A, Rupani H, Gates J, Fox L, Wiffen L, Chauhan AJ. A Study to Investigate the Prevalence of Device-Specific Errors in Inhaler Technique in Adults With Airway Disease (The SCORES Study): Protocol for a Single Visit Prevalence Study. JMIR Res Protoc. 2021 Aug 27;10(8):e26350. doi: 10.2196/26350.
PMID: 34448728DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2020
First Posted
February 10, 2020
Study Start
August 7, 2019
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
April 10, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share